Endovascular treatment of anterior cranial fossa dural arteriovenous fistula: a multicenter series
| Autor: | Brian M. Howard, Osman Kizilkilic, Carlos Díaz, Peter Kan, Guilherme Dabus, Italo Linfante, Viraj M. Moholkar, Boris Pabón, Michael W. McDermott, Ajit S. Puri, Edgar A. Samaniego, Naci Kocer, Jonathan A Grossberg, Anna Luisa Kühn, Civan Islak, Juan Andres-Mejia, Santiago Ortega-Gutierrez |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Neurology Adolescent medicine.medical_treatment Arteriovenous fistula 030218 nuclear medicine & medical imaging 03 medical and health sciences Young Adult 0302 clinical medicine Modified Rankin Scale Medicine Humans Radiology Nuclear Medicine and imaging Embolization Neuroradiology Aged Retrospective Studies Central Nervous System Vascular Malformations Cranial Fossa Anterior business.industry Endovascular Procedures Middle Aged medicine.disease Embolization Therapeutic Surgery medicine.anatomical_structure Treatment Outcome Anterior cranial fossa Female Neurology (clinical) Neurosurgery Cardiology and Cardiovascular Medicine business Complication 030217 neurology & neurosurgery |
| Zdroj: | Neuroradiology. 63(2) |
| ISSN: | 1432-1920 |
| Popis: | We report a multicenter experience using endovascular embolization as the first line approach for treatment of anterior cranial fossa (ACF) dural arteriovenous fistula (DAVF). All patients with DAVFs located in the anterior cranial fossa who were treated with endovascular technique as a first line approach were included. Demographics, clinical presentation, angioarchitecture, strategy, complications, immediate angiographic, and follow-up results were included in the analysis. Twenty-three patients met the inclusion criteria (18 male and 5 female). Age ranged from 14 to 79 years (mean 53 years). Twelve patients presented with hemorrhage. Twenty-eight endovascular procedures were performed. The overall immediate angiographic cure rate after endovascular treatment was 82.6% (19/23 patients). The angiographic cure rate of the transvenous strategy was significantly superior to the transarterial strategy (p ≤ 0.001). There was 1 complication in 28 total procedures (3.6%). Angiographic follow-up was available in 21 out of the 23 patients with a mean of 25 months (range 2 to 108 months). In these 21 patients, the DAVF was completely cured in 20 (95%). At last follow-up, all patients had a modified Rankin scale (mRS) 0 to 2. Our experience suggests that endovascular treatment for ACF DAVFs has an acceptable safety profile with high rates of complete occlusion, particularly with transvenous approach. Whenever possible, transvenous approach should be preferred over transarterial approach as first line strategy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink